
US lawmakers launch investigation into FDA approval and price of new Alzheimer's drug
CNN
Two House committees have launched an investigation into the approval and pricing of the Alzheimer's disease drug aducanumab, made by the company Biogen and sold under the brand name Aduhelm.
The US Food and Drug Administration approved the drug earlier this month under its "accelerated approval" program, although an FDA advisory committee concluded last year that there was not enough evidence to support the effectiveness of the treatment.
A federal judge on Friday blocked President Donald Trump’s administration from enforcing most of his executive order on elections against the vote-by-mail states Washington and Oregon, in the latest blow to Trump’s efforts to require documentary proof of citizenship to vote and to require that all ballots be received by Election Day.

A Border Patrol agent shot two people in Portland, Oregon, during a traffic stop after authorities said they were associated with a Venezuelan gang, another incident in a string of confrontations with federal authorities that have left Americans frustrated with immigration enforcement during the Trump administration.











